GlassScriptPhysician profile
Eric L Wyatt
NPI 1417007139
$2,921.08
in general payments reported to CMS, 2019-2025
47 companies · $662 in 2025
The $662 reported for 2025 was more than what a typical Procedural Dermatology provider received nationally (typical 2025 total: $599).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $66.25 · 2020: $160 · 2021: $470 · 2022: $733 · 2023: $398 · 2024: $432 · 2025: $662.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,475 · Education: $15.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,475.39 |
| Education | $15.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $202.33 | 2020-2025 | |
| Daiichi Sankyo INC. | $193.94 | 2020-2025 | Enhertu, Datroway |
| Incyte Corporation | $181.55 | 2020-2025 | Jakafi, Monjuvi |
| Alexion Pharmaceuticals, INC. | $179.50 | 2020-2024 | Ultomiris |
| Regeneron Healthcare Solutions, INC. | $164.72 | 2019-2025 | Libtayo |
| Astrazeneca Pharmaceuticals LP | $156.89 | 2019-2024 | Enhertu |
| Pharmacosmos Therapeutics INC. | $154.14 | 2021-2025 | Monoferric, Cosela |
| Amgen INC. | $140.41 | 2022 | |
| Seagen INC. | $134.63 | 2020-2023 | Tukysa, Adcetris |
| Janssen Biotech, INC. | $118.88 | 2023-2025 | Carvykti, Rybrevant, Erleada |
| Takeda Pharmaceuticals U.S.A., INC. | $116.18 | 2019-2025 | Ninlaro, Iclusig |
| Array Biopharma INC | $112.11 | 2022-2025 | Mektovi, Braftovi, Xalkori |
| Genzyme Corporation | $110.13 | 2021-2025 | |
| Legend Biotech USA INC. | $79.36 | 2025 | Carvykti |
| Pharmacyclics LLC, An Abbvie Company | $63.68 | 2020-2021 |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Wyatt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.